PERTURBATION BIOLOGY
BUILDING HUMAN-RELEVANT PERTURBATION DATA THAT THE AI-BIO FIELD NEEDS
Current technologies fail to deliver cell-perturbation reagents into disease-relevant cells – a bottleneck for target discovery AI.
Aparna Bio is developing ENTECH to remove this delivery constraint.
01 — PROBLEM
Current delivery methods fail in primary human cells, leaving the most disease-relevant models out of reach for AI-driven target discovery.
02 — SOLUTION
ENTECH is a next-generation delivery platform engineered to unlock perturbation in primary and disease-relevant human cell types at scale.